The Protecting American Families and Servicemembers from Anthrax Act tasks the Secretaries of Health and Human Services and Defense with developing a modernized, 10-year strategy to sustain stockpiles of anthrax countermeasures. The plan contemplates stockpiles in the Strategic National Stockpile and in DoD installations, with a focus on replenishment aligned to requirement levels and on ensuring durable partnerships with manufacturers.
The bill also requires an initial threat assessment and implementation plan within 180 days, plus ongoing annual updates to Congress, with the option to classify the core material while allowing an unclassified annex.
At a Glance
What It Does
The act requires a 10-year modernized strategy for sustaining anthrax countermeasures stockpiles, due within 180 days of enactment, covering SNS inventories or DoD stockpiles on military installations.
Who It Affects
Implementation rests with the HHS Assistant Secretary for Preparedness and Response and the DoD Assistant Secretary for Nuclear, Chemical, and Biological Defense Programs; manufacturers of countermeasures; and military personnel and dependents (including those overseas).
Why It Matters
It establishes a formal, long-term supply and cooperation framework to keep countermeasures available, adaptable to multi-year budgets, R&D, and procurement, and it embeds ongoing Congressional oversight through classified reporting.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill creates a clear mandate for a modernized, 10-year strategy to maintain a steady stock of anthrax countermeasures. The strategy must be developed by the two most directly responsible federal offices—the Department of Health and Human Services and the Department of Defense—within 180 days of enactment.
It recognizes two stockpile channels: the Strategic National Stockpile and DoD inventories on military installations, including those abroad, with an emphasis on replenishment in line with current requirements and on sustaining production through ongoing relationships with manufacturers.
Beyond the strategy itself, the bill sets out a robust reporting framework. An initial report, due within 180 days, must cover the current and prospective threat landscape—specifically weaponized anthrax from foreign actors and other threat streams—as well as federal programs (excluding certain PHME-related items) that would support the modernized strategy.
Importantly, it calls out initiatives to ensure availability of countermeasures for treatment of military dependents stationed at foreign postings. The initial report must be submitted to the appropriate congressional committees and, thereafter, annual updates are required.
Both the initial report and updates can be classified, with the option of an unclassified annex to aid oversight.Definitions anchor the bill: an “anthrax countermeasure” includes FDA-approved drugs, devices, or biological products, and can encompass antitoxins and prophylactics. The bill also defines who the “covered Secretaries” are and who constitutes the relevant congressional committees, ensuring tight governance and cross-agency responsibility.Overall, the act creates a formal, cross-agency program to future-proof the nation’s anthrax defenses, with a built-in mechanism for continuous assessment and oversight while preserving the flexibility to keep sensitive information classified when necessary.
The Five Things You Need to Know
The bill directs a 10-year modernized strategy for sustained anthrax countermeasure stockpiling.
A 180-day deadline applies for developing the strategy after enactment.
An initial 180-day report must assess foreign and other anthrax threats and current programs supporting the strategy.
Annual updates to the report are required, with classification allowed and an annex possible.
Definition of “covered Secretaries” ties HHS and DoD leadership to the Public Health Emergency Medical Countermeasures Enterprise (PHME).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
The act may be cited as the Protecting American Families and Servicemembers from Anthrax Act.
Modernized strategy to defend against anthrax
Not later than 180 days after enactment, the Secretary of Health and Human Services and the Secretary of Defense, acting jointly, must develop a modernized 10-year strategy for sustained stockpiling of anthrax countermeasures. The strategy must address stockpiles in the Strategic National Stockpile under the Public Health Service Act or in DoD stockpiles on military installations, and it should emphasize replenishment aligned with requirement levels and ongoing collaboration with manufacturers to ensure supply and innovation.
Reporting requirements
Within 180 days of enactment, the Secretaries must submit a report to the appropriate congressional committees describing the threat to people and military sites from weaponized anthrax and other threat streams, and detailing federal programs (beyond PHME-related activities) that support the modernized strategy, including initiatives to guarantee countermeasure availability for treatment of dependents on U.S. bases abroad. The report must include the modernized strategy itself and be followed by annual updates.
Definitions and scope
Key terms are defined to guide implementation: an “anthrax countermeasure” includes FDA-approved drugs, devices, or biological products, including antitoxins and prophylactics; and “covered Secretaries” means the HHS secretary (via the Assistant Secretary for Preparedness and Response) and the DoD secretary (via the Assistant Secretary for Nuclear, Chemical, and Biological Defense Programs), acting jointly with PHME Enterprise.
This bill is one of many.
Codify tracks hundreds of bills on Defense across all five countries.
Explore Defense in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Military personnel and dependents in U.S. and overseas postings, who gain reliable access to countermeasures through a stabilized stockpile and ongoing replenishment requirements.
- Federal stockpile program managers and procurement agencies, who gain a clear, long-range framework for planning, budgeting, and interoperability between SNS and DoD inventories.
- Manufacturers of anthrax countermeasures, who benefit from a formal, sustained demand trajectory and a collaboration framework to support R&D and supply chain resilience.
- Congressional oversight committees, which gain structured, periodic, and potentially classified reporting to monitor readiness and risk.
Who Bears the Cost
- DoD and HHS to fund and manage the expanded stockpile and its governance, including cross-agency coordination.
- Manufacturers and suppliers who must meet production, quality, and delivery obligations under a multi-year stockpile program.
- Taxpayers, who may bear the fiscal cost of maintaining a robust national stockpile and the associated administrative overhead.
Key Issues
The Core Tension
The central dilemma is balancing a robust, long-term defense stockpile with the realities of budgeting, cross-agency coordination, and the private-sector market’s capacity to sustain a stable supply of countermeasures, all while preserving the ability to keep sensitive threat information classified when necessary.
This bill creates a robust framework for stockpile planning and reporting, but it also raises questions about the cost and feasibility of a long-term, cross-agency stockpile program. The requirement to classify core threat assessments and strategy materials could complicate oversight, though an unclassified annex is allowed.
The split between SNS and DoD stockpiles raises governance and interoperability considerations, particularly for how replenishment, procurement, and contracting will be coordinated across two fundamentally different stockpile ecosystems. The reliance on manufacturer cooperation to sustain supply is sensible but may prove vulnerable to market dynamics, regulatory hurdles, and global events.
These tensions are acknowledged in the bill’s structure, but practical timelines and funding paths will determine whether the strategy can be effectively implemented.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.